Trial intelligence / Profile preview

FMT in Peripheral Psoriatic Arthritis

NCT03058900Completed

Sponsor
University Hospital Odense
Start
May 2017
Primary completion
Jun 2020
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Randomised, double-blind trial in psoriatic arthritis (PsA) comparing Fecal microbiota transplantation (FMT) with Placebo (saline) (2 arms). Primary endpoint: Treatment failure at 6 months. Started May 2017; status: completed.

02

Drugs

allogeneic fecal microbiota
03

Conditions

psoriatic arthritis (PsA)

Beyond the preview

Go deeper on NCT03058900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03058900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call